Arcellx, Inc.

NasdaqGS:ACLX Stock Report

Market Cap: US$4.7b

Arcellx Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ACLX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Mar 24SellUS$56,440,000SR One Capital Management, LPCompany800,000US$70.55
12 Feb 24SellUS$2,410,740Rami ElghandourIndividual38,065US$64.46
12 Feb 24SellUS$640,352Christopher HeeryIndividual10,111US$64.46
04 Jan 24SellUS$1,606,804Rami ElghandourIndividual29,073US$55.27
04 Jan 24SellUS$470,551Michelle GilsonIndividual8,514US$55.27
04 Jan 24SellUS$419,926Christopher HeeryIndividual7,598US$55.27
14 Dec 23SellUS$39,304,000SR One Capital Management, LPCompany800,000US$49.13

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ACLX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders130,6150.224%
Hedge Funds3,848,0956.61%
Public Companies6,720,80311.5%
VC/PE Firms7,635,00113.1%
Institutions39,917,43368.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.2%.

Top Shareholders

Top 25 shareholders own 94.15% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.5%
Gilead Sciences, Inc.
6,720,803US$585.5m0%no data
12.1%
FMR LLC
6,487,272US$565.2m20.3%0.03%
7.9%
BlackRock, Inc.
4,246,692US$370.0m20.8%0.01%
7.24%
Perceptive Advisors LLC
3,889,739US$338.9m-1.11%6.9%
7.16%
Paradigm Biocapital Advisors LP
3,848,095US$335.2m0.79%10.67%
6.97%
New Enterprise Associates, Inc.
3,745,262US$326.3m0%15.01%
5.22%
T. Rowe Price Group, Inc.
2,804,481US$244.3m20.5%0.02%
4.37%
SR One Capital Management, LP
2,346,630US$204.4m0%35.59%
4.27%
The Vanguard Group, Inc.
2,296,195US$200.0m3.02%no data
3.54%
Janus Henderson Group plc
1,902,618US$165.8m25%0.07%
3.27%
State Street Global Advisors, Inc.
1,755,664US$153.0m-6.87%0.01%
2.98%
RA Capital Management, L.P.
1,604,014US$139.7m0%1.52%
2.84%
Cormorant Asset Management, LP
1,525,000US$132.9m-14.3%5.93%
2.82%
Suvretta Capital Management, LLC
1,516,254US$132.1m-2.95%4.64%
1.74%
Geode Capital Management, LLC
935,186US$81.5m11.5%0.01%
1.63%
Lord, Abbett & Co. LLC
873,844US$76.1m-27.1%0.23%
1.26%
Vestal Point Capital, LP
675,000US$58.8m575%3.89%
0.96%
Morgan Stanley, Investment Banking and Brokerage Investments
516,309US$45.0m-21.2%0.01%
0.92%
Great Point Partners, LLC
492,000US$42.9m64%7.66%
0.86%
Affinity Asset Advisors, LLC
460,000US$40.1m53.3%6.33%
0.84%
Samsara BioCapital LLC
453,641US$39.5m0%5.03%
0.83%
Deutsche Asset & Wealth Management
446,530US$38.9m-0.28%0.01%
0.7%
UBS Asset Management AG
373,959US$32.6m1.37%no data
0.65%
Northern Trust Global Investments
350,580US$30.5m-2.47%no data
0.64%
Baron Capital Group, Inc.
342,760US$29.9m37.7%0.07%